MindRank raises $52.0M Series B (Jul 2026)
$52.0M
$52M Series BGenerated social card
Headline
MindRank Closes $52M Series B for GLP-1 Drug - AllSci
About
MindRank is a biotechnology company focused on developing GLP-1 drugs. This funding round will help advance their innovative treatments aimed at addressing metabolic disorders. The $52 million raised will support their clinical trials and further research.
Article summary
MindRank Closes $52M Series B for GLP-1 Drug AllSci
Investors
Related rounds
| Aug 14, 2026 | MiiHealth AI | $2.8M | — | United States |
| Aug 14, 2026 | Khartis | $95.0M | — | — |
| Aug 14, 2026 | InduPro | $77.0M | Series B | United States |
| Aug 13, 2026 | Wondermind | $1.2M | — | — |